Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

Ebola virus is the primary contributor to the global threat of filovirus severe hemorrhagic fever, and Ebola virus disease has a case fatality rate of 50–90%. An inactivated, bivalent filovirus/rabies virus vaccine, FILORAB1, consists of recombinant rabies virus virions expressing the Ebola virus gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yankowski, Catherine, Kurup, Drishya, Wirblich, Christoph, Schnell, Matthias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906604/
https://www.ncbi.nlm.nih.gov/pubmed/36754965
http://dx.doi.org/10.1038/s41541-023-00615-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906604/
https://www.ncbi.nlm.nih.gov/pubmed/36754965
http://dx.doi.org/10.1038/s41541-023-00615-z

Ejemplares similares